KAL1 Antikörper (AA 131-230) (FITC)
-
- Target Alle KAL1 Antikörper anzeigen
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
-
Bindungsspezifität
- AA 131-230
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KAL1 Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Homologie
- Human,Rat,Dog,Sheep,Pig,Horse,Chicken
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human Anosmin-1
- Isotyp
- IgG
- Top Product
- Discover our top product KAL1 Primärantikörper
-
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 200-300) antibody
KAL1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) antibodyKAL1 Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E8 unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 166-194), (N-Term) antibodyKAL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB39497 unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (Internal Region) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
- Andere Bezeichnung
- Anosmin 1 (KAL1 Produkte)
- Synonyme
- ADMLX antikoerper, HH1 antikoerper, HHA antikoerper, KAL antikoerper, KALIG-1 antikoerper, KMS antikoerper, WFDC19 antikoerper, KAL1 antikoerper, hha antikoerper, kal antikoerper, kms antikoerper, admlx antikoerper, kalig-1 antikoerper, anosmin-1a antikoerper, kal1.1 antikoerper, kal1a antikoerper, wu:fl91z45 antikoerper, anosmin 1 antikoerper, anosmin 1a antikoerper, ANOS1 antikoerper, anos1 antikoerper, anos1a antikoerper
- Hintergrund
-
Synonyms: KAL, Adhesion molecule-like X-linked, ADMLX, Anosmin-1, HHA, KAL1, KALIG 1, KALIG1, Kallmann syndrome 1 sequence anosmin 1, Kallmann syndrome interval gene 1, Kallmann syndrome protein, KALM, KALM_HUMAN, KMS.
Background: May be an adhesion-like molecule with anti-protease activity.
-
